Teva to Pay $519 Million in U.S. Probe Over Foreign Bribes
- Drugmaker admits paying bribes in Russia, Mexico, Ukraine
- Penalty is among the 10 largest over FCPA violations
This article is for subscribers only.
Teva Pharmaceutical Industries Ltd. agreed to pay $519 million to U.S. authorities after admitting to paying bribes in Russia, Ukraine and Mexico to boost sales.
Teva, the world’s biggest maker of generic medicines, admitted to making corrupt payments to public officials and doctors, including an unidentified high-ranking Russian government official, according to a statement Thursday by the Justice Department. The agreement also resolves a parallel investigation by the Securities and Exchange Commission. A Russian subsidiary of Teva agreed to .